OSE Immunotherapeutics Reports First Half 2025 Financial Results NANTES, France, October 15, 2025 - 7:00pm CET - OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE), today reported its consolid ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback